Vasculature and microenvironmental gradients: The missing links in novel approaches to cancer therapy?

Advances in Enzyme Regulation

Volumn 38, Issue 1, 1998, Pages 281-299

  Denekamp, Juliana ^a   Daşu, Alexandru ^a   Waites, Anthony ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ACTIVITY; CANCER; CANCER RESEARCH; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; DRUG EFFECT; EXPERIMENTAL NEOPLASM; HUMAN; MICROCIRCULATION; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; SOLID TUMOR; TUMOR BLOOD FLOW;

CELL HYPOXIA; CELL SURVIVAL; MICROCIRCULATION; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0345055815     PISSN: 00652571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0065-2571(97)00015-0     Document Type: Conference Paper

References (44)

1. R. K. JAIN, Determinants of tumour blood flow: a review, Cancer Res. 48, 2641-2658 (1988).
2. J. DENEKAMP, Vascular attack as a therapeutic strategy for cancer, Cancer Metastases Rev. 9, 267-282 (1990).
3. J. DENEKAMP, Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy, Brit. J. Radiol. 66, 181-196 (1993).
4. P. F. RIJKEN, H. J. BERNSEN and A. J. VAN DER KOGEL, Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts, Microvasc. Res. 50, 141-153 (1995).
5. J. BUSSINK, J. H. A. M. KAANDERS and P. F. J. W. RIJKEN, Multi-parameter analysis of vasculature, perfusion and proliferation in human tumour xenografts, Brit. J. Cancer 77, 57-64 (1997).
6. R. H. THOMLINSON and L. H. GRAY, The histological structure of some human lung cancers and the possible implications for radiotherapy, Brit. J. Cancer 9, 539-549 (1955).
7. R. J. HODGKISS and P. WARDMAN, The measurement of hypoxia in tumours, pp. 105-122. in: Radiation Science - Of Molecules, Mice and Men, suppl. 24 (J. DENEKAMP and D. G. HIRST, eds.). British Institute of Radiology, London (1992).
8. th edition, J.B. Lippincott, Philadelphia, (1994).
9. J. DENEKAMP and M. C. JOINER, The potential benefit from a perfect radiosensitizer and its dependence on reoxygenation, Brit. J. Radiol. 55, 657-663 (1982).
10. B. G. WOUTERS and J. M. BROWN, Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy, Radiat. Res. 147, 541-550 (1997).
11. J. FOLKMAN, What is the evidence that tumours are angiogenesis dependent?, J. Natl. Cancer Inst. 82, 4-6 (1990).
12. J. FOLKMAN, E. MERLER, C. ABERNATHY and G. WILLIAMS, Isolation of a tumor factor responsible for angiogenesis, J. Exptl. Med. 133, 275-288 (1971).
13. I. STEIN, M. NEEMAN, D. SHWEIKI, A. ITIN and E. KESHET, Stabilization of vascular endothelial growth factor MRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes, Mol. Cell. Biol. 15, 5363-5369 (1995).
14. J. DENEKAMP and B. HOBSON, Endothelial cell proliferation in experimental tumours, Brit. J. Cancer 46, 711-720 (1982).
15. B. HOBSON and J. DENEKAMP, Endothelial proliferation in relation to vasculature, Cell Tissue Kinetics 12, 31-42 (1984).
16. B. HOBSON and J. DENEKAMP, Endothelial proliferation in tumours and normal tissues: Continuous labelling studies, Brit. J. Cancer 49, 405-413 (1984).
17. B. S. FOX, K. C. GATTER, R. BICKNELL, J. J. GOING, P. STANTON, T. G. COOKE and A. L. HARRIS, Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer, Cancer Res. 53, 4161-4163 (1993).
18. P. B. VERMEULEN, D. VERHOEVEN, G. HUBENS, E. VAN MARCK, G. GOOVAERTS, M. HUYGHE, E. A. BRUIJN, A. T. VAN OOSTEROM and L. Y. DIRIX, Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas, Ann. Oncol. 6, 59-64 (1995).
19. J. DENEKAMP, Endothelial cell proliferation as a novel approach to targeting tumour therapy, Brit. J. Cancer 45, 136-139 (1982).
20. H. B. STONE, J. M. BROWN, T. L. PHILLIPS and R. M. SUTHERLAND, Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland, Radiat. Res. 136, 422-434 (1993).
21. J. E. MOULDER and S. ROCKWELL, Hypoxic fractions of solid tumors: experimental techniques, methods of analysis and survey of existing data, Int. J. Radiat. Oncol. Biol. Phys. 10, 695-712 (1984).
22. J. M. YUHAS, J. M. SPELLMAN and F. CULO, The role of WR-2721 in radiotherapy and/or chemotherapy, Cancer Clin. Trials 3, 211-216 (1980).
23. A. ROJAS and J. DENEKAMP, Experimental radiotherapy with WR-2721 and misonidazole, Int. J. Radiat. Oncol. Biol. Phys. 8, 527-530 (1982).
24. J. DENEKAMP, A. ROJAS and G. STEVENS, Redox competition and radiosensitivity: implications for testing radioprotective compounds, Pharmacol. Ther. 39, 59-66 (1988).
25. J. DENEKAMP, F. A. STEWART and A. ROJAS, Is the outlook grey for WR-2721 as a clinical radioprotector?, Int. J. Radiat. Oncol. Biol. Phys. 9, 1247-1249 (1983).
26. R. S. MARSHALL and A. M. RAUTH, Oxygen and exposure kinetics as factors influencing the cytotoxicity of porfiromycin, a mitomycin C analogue, in Chinese hamster ovary cells, Cancer Res. 48, 5655-5659 (1988).
27. J. M. BROWN and M. J. LEMMON, Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors, Cancer Res. 50, 7745-7749 (1990).
28. M. C. JOINER, J. DENEKAMP and R. L. MAUGHAN, The use of top-up experiments to investigate the effects of very small doses per fraction in mouse skin, Int. J. Radiat. Biol. 49, 565-580 (1986).
29. M. C. JOINER and H. JOHNS, Renal damage in the mouse: The response to very small doses per fraction, Radiat. Res. 114, 385-398 (1988).
30. B. MARPLES and M. C. JOINER, The response of Chinese hamster V79 cells to low radiation doses: evidence of enhanced sensitivity of the whole cell population, Radiat. Res. 133, 41-51 (1993).
31. P. LAMBIN, E. P. MALAISE and M. C. JOINER, Might intrinsic radioresistance of human tumour cells be induced by radiation?, Int. J. Radiat. Biol. 69, 279-290 (1996).
32. A. DAŞU and J. DENEKAMP, New insights into factors influencing the clinically relevant oxygen enhancement ratio, Radiother. Oncol. (in press).
33. T. J. GRABER, C. OSMANIAN, T. JACKS, D. E. HOUSMAN, C. J. KOCH, S. W. LOWE and A. J. GIACCIA, Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours, Nature 379, 19-20 (1996).
34. R. M. SUTHERLAND and R. E. DURAND, Radiation response of multicell spheroids - an in vitro tumour model, Curr. Topics Radiat. Res. Quart. 11, 87-139 (1976).
35. D. INGBER, T. FUJITA, S. KISHIMOTO, K. SUDO, T. KANAMARU, H. BREM and J. FOLKMAN, Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth, Nature 348, 555-557 (1990).
36. J. FOLKMAN, New perspectives in clinical oncology from angiogenesis research, Eur. J. Cancer 32A, 2534-2539 (1996).
37. J. DENEKAMP, S. A. HILL and B. HOBSON, Vascular occlusion and tumour cell death, Eur. J. Cancer Clin. Oncol. 19, 271-275 (1983).
38. D. G. HIRST, J. DENEKAMP and B. HOBSON, Proliferation kinetics of endothelial and tumour cells in three mouse mammary carcinomas, Cell Tissue Kinet. 15, 251-261 (1982).
39. S. A. HILL, K. B. WILLIAMS and J. DENEKAMP, Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action, Eur. J Cancer Clin. Oncol. 25, 1419-1424 (1989).
40. S. A. HILL, K. A. SMITH and J. DENEKAMP, Stromal sensitivity to radiation and hyperthermia, Brit. J. Cancer 56, 383-388 (1987).
41. B. C. BAGULEY, S. B. CALVELEY, K. K. CROWE, L. M. FRAY, S. A. O'ROURKE and G. P. SMITH, Comparison of the effects of flavone acetic acid, fostriecin, homohairingtonine and tumour necrosis factor α on colon 38 tumors in mice, Eur. J. Cancer Clin. Oncol. 25, 263-269 (1989).
42. G. G. DARK, S. A. HILL, V. E. PRISE, G. M. TOZER, G. R. PETTIT and D. J. CHAPLIN, Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature, Cancer Res. 57, 1829-1834 (1997).
43. A. C. BEGG, Prediction of repopulation rates and radiosensitivity in human tumours, Int. J. Radiat. Biol. 65, 103-108 (1994).
44. C. BERGSTRÖM, R. PALMQVIST, J. DENEKAMP, Å ÖBERG, B. TAVELIN and R. STENLING, Factors influencing the estimates of proliferative labelling indices in rectal cancer, Radiother Oncol (in press).